Outline H1N1 vs. SARS-COV-2

Part I 

COVID/SARS-COV-2 virus

Ending COVID

Regarding: H1N1

Prevention

Flu/influenza/H1N1

Flu virus changes annually/cycle

Prevention/ how to avoid getting the flu

Obtain a flu shot and wash hands

Flu vaccine is available for prevention

Case of Infection

What to do if infected with the H1N1 virus

If contract the flu, expect around 2 weeks or more of symptoms attacking the respiratory system 

(Refer to symptoms)

If within normal age range, can obtain OTC products to alleviate ailments

If severe symptoms persist, proceed to the hospital to receive treatment

Containment/Spread of the Flu/H1N1 virus

Containment for the flu virus is not possible at this time because the vast majority of the population has already been exposed

Basic health precautions to avoid the flu virus are washing hands and staying clean. 

Social distance policies and avoiding workplace and private environments are not appropriate for relevant healthcare measures. Utilizing cloth on face/hands for blockage of viral infection as mandatory seems severe.

It does not appear to be feasible for enforcement of health mandates to the general population regarding the virus.

Part II

COVID/SARS-COV-2

Ending COVID

Prevention

Vaccine works high %(+)

Infection (+) test results

Infection

Contraction of COVID

most likely mild/flu symptoms (age)

Severe case then hospitalized

Treatment works (for vast majority)

Containment

(not feasible)

Most Americans have already been 

exposed. Antibodies for immunity are

present throughout the population

Innate immunity

Additional information regarding Covid related informational material can be found at: EndingCOVID19

Tobacco Leads to the Development of Chronic Obstructive Pulmonary Disease & Contracting Viral Respiratory Infections

Ending COVID

Smoking, Tobacco, & Second-Hand Smoke Contribute to the Development of Contracting Chronic Obstructive Pulmonary Disease, Which Increases the Susceptibility to Respiratory Based Viral Infections 

Chronic Obstructive Pulmonary Disease (COPD)

When observing the major causes of death for the human population in the United States, chronic lower respiratory diseases are the 4th leading cause of death for Americans. Chronic lower respiratory diseases include: asthma, COPD, bronchitis, emphysema, lung cancer, etc. Medical ailments from these diseases can include: difficulty breathing, chest tightness, a collapse of part or all of the lung (pneumothorax or atelectasis), swelling and inflammation in the main passages (bronchial tubes) that carry air to the lungs (bronchitis), and an eventual painful suffocating death. 

In order to live a healthy life, it is important to avoid things that can contribute to the decline of the immune system. When it comes to respiratory viruses, the primary organs that need to be kept in good working order are the lungs. As of 2020 the major contributor to the destruction of lung health is tobacco. 

The damage that tobacco and smoking cause to lung health is significant and has resulted in it being classified as the first carcinogen and 4th leading cause of death in the United States. Usage of cigarettes or being around second hand smoke is the leading cause of COPD. Exposure to tobacco and cigarette smoke is the main cause of chronic obstructive pulmonary disease. 

COPD is a condition where there is a build-up of mucus in the lungs (the mucus serves to protect epithelia cells in the linings of the respiratory system becomes inflamed). Results in a loud, congested, painful cough, along with excruciating breathing difficulties. The carcinogenic toxins found in cigarette smoke, will weaken the lungs defense against all infections, narrow the air passages, and cause swelling in air tubes and destroy air sacs—all contributing factors for chronic obstructive pulmonary disease (COPD). Injured lungs will make it difficult to inhale and exhale oxygen into and out of the body which will make it difficult to breathe. 

The leading cause of COPD is smoking. Cigarette smoke can directly lead to the development of COPD symptoms and also indirectly through second hand smoking effects. Exposure to another person smoking, or being in the environment where someone has previously smoked can directly impact lung health. 

The vast majority of deaths associated with tobacco are from lung diseases like cancer, chronic respiratory diseases (COPD) and tuberculosis. Lung cancer deaths are primarily caused by tobacco, with over 2/3 of lung cancer deaths worldwide. Second-hand smoke exposure anywhere will also increase the chances of acquiring lung cancer.

The single largest health preventable cause of death and disease for Americans in the United States is tobacco usage.  Around 480,000 Americans die each year due to cigarette smoking. In 2018, an estimated 13.7% (34.2 million) of U.S. adults were cigarette smokers.  Of these, (34.2 million) 74.6% Americans smoked every day. 

In addition, tobacco/smoking-related medical illness in the US costs more than $300 billion annually, including at least $170 billion in direct medical care for adults who smoke and $156 billion in lost productivity in the American workforce due to cigarette smokers.  

Respiratory system diseases/COPD 

    Smoking/Carcinogen/Lungs/Squamous Alveolar Cells

    Asthma/Bronchitis/Lung Cancer/Death 

    Lung damage/weak immune system/viral infection

Regarding Second hand smoke

    Long term ramifications/smoke/carcinogen in air 

    Home/Auto smoke free 

    Smoke on clothes/walls/carpets

    Smoke-free apartments/restaurants/workplaces/environments

    Avoid public places that allow smoking 

Phase I/II Clinical Trial Results from COVID-19 RNA based SARS-CoV-2 Vaccine BNT162b1 in Adults

Phase I/II Clinical Trial Results from COVID-19 RNA based SARS-CoV-2 Vaccine BNT162b1 in Adults BNT162b1 

BNT162b1 is a lipid-nanoparticle-formulated, nucleoside-modified mRNA vaccine that encodes the trimerized receptor-binding domain (RBD) of the spike glycoprotein of SARS-CoV-2. BNT162b1 is one of several RNA-based SARS-CoV-2 vaccine candidates. Data shows that up to 14 days after a second dose in adults (18–55 years of age) from an ongoing phase I/II vaccine study with BNT162b1, which is also enrolling adults who are 65–85 years of age. Possible side effects included only all local reactions which were mild or moderate in severity, except for one report of severe pain after the first dose of 100 μg BNT162b1. Other symptoms reported in the 7 days after each vaccination in both BNT162b1 and placebo groups were mild to moderate fatigue and headache. The largest changes were decreases in the lymphocyte count after the first dose in 8.3% (1 out of 12), 45.5% (5 out of 11) and 50.0% (6 out of 12) of participants who received 10 μg, 30 μg and 100 μg BNT162b1, respectively. One participant each in the 10-μg (8.3% (1 out of 12)) and 30-μg (9.1% (1 out of 11)) groups and 4 participants in the 100-μg group (33.3% (4 out of 12)) had grade 3 decreases.    

For all doses, small increases in SARS-CoV-2-neutralizing geometric mean titres (GMTs) were observed 21 days after the first dose. Overall, robust immunogenicity was observed after vaccination with BNT162b1. Neutralization provides a measure of the vaccine-elicited antibody response that is more relevant to potential protection. RNA-based prophylactic infectious-disease vaccines and RNA therapeutic agents have been shown to be safe and well-tolerated in clinical trials. Vaccination with RNA elicits a robust innate immune response. RNA directs the expression of the vaccine antigen in host cells and has intrinsic adjuvant effects. RNA-vaccine manufacturing platform—irrespective of the encoded pathogen antigen—is the ability to rapidly produce large quantities of vaccine doses against a new pathogen. Safety, tolerability and immunogenicity data from an ongoing placebo-controlled, observer-blinded dose-escalation study (identifier NCT04368728) among 45 healthy adults (18–55 years of age), who were randomized to receive 2 doses—separated by 21 days—of 10 μg, 30 μg or 100 μg of BNT162b1. 

Overall local reactions and systemic events were dose-dependent, generally mild to moderate, and transient. A second vaccination with 100 μg was not administered because of the increased reactogenicity and a lack of meaningfully increased immunogenicity after a single dose compared with the 30-μg dose. RBD-binding IgG concentrations and SARS-CoV-2 neutralizing titres in sera increased with dose level and after a second dose. Geometric mean neutralizing titres reached 1.9–4.6-fold that of a panel of COVID-19 convalescent human sera, which were obtained at least 14 days after a positive SARS-CoV-2 PCR.

Removing Social Distancing Policies Pertaining to Social Gatherings in the United States

Ending COVID 

Public Health Measures Regarding COVID Social Interactions in the US

Social Gatherings For the Holidays

The following is pertaining to the COVID situation regarding whether the American public can engage in social gatherings in private and public environments during the upcoming holiday season. At the current time it is within reason to resume all normal activities regarding social gatherings without the concern of adverse long term health ramifications concerning COVID. 

The vast majority of the public has been exposed to the virus in the United States and it is no longer considered a threat. Areas of concern only pertain to the segment of the population which is immuno-compromised, such as those with pre-existing/on-going health conditions, disabilities, and the elderly.   

Starting with transportation, regarding if it is appropriate to travel in automobiles, airplanes, etc. at the current time throughout the United States. Current incoming data implies that large segments of the population is utilizing public and private transportation in order to move around the country without incurring adverse health effects. 

Pertaining to air travel, there are several airlines which are currently operating in the US at full capacity (booked out flights). Concerns regarding the spread of the COVID virus due to mass transport of individuals from one area to another are not relevant at this time. 

Case study statistics from the states of California and Texas can be used to show that there are already millions of COVID positive individuals in the region. COVID (+) positive test results from states such as California where over a million individuals have tested positive (+) in a overall population of 39.78 million. As well as the state of Texas, which also has over a million positive COVID (+) individuals moving around the region freely (no quarantine), in a population of over 29.90 million. Both imply that the vast majority of the population has already been exposed to or infected with the COVID virus and are either mild cases or asymptomatic. 

Since these are two of the most heavily populated states in the country, and both have upwards of millions of individuals who have been exposed to or infected with COVID; it is clear that the virus has surpassed any measures of containment. Enforcing public health mandates to a population at this time, will no longer have the impact intended of containing the spread of the virus (2019). 

Educating the public to practice general hygiene practices in order to prevent illness and the spread of disease is a practical measure to reduce the rates of viral infections. Similar to concerns regarding preventing the spread of influenza/H1N1/SARS/flu/cold/respiratory diseases/viral/bacterial/etc.

Age specific guidelines regarding who can travel without severe health ramifications is directly corelated to the strength of the immune system. Age demographics pertaining to the level of how strong the immune system of the individual are the following. (1-5), (6-10), (11-20), (20-30) (31-40), (41-45), (46-50), (51-55),(56-60), (61-65), (66-70), (71-75), (76-80), (81-85), (86-100). Those past the age of 60 are at a higher chance of being infected with general respiratory viruses along with any individuals who have pre-existing health conditions. However the health benefits of socializing for the same age bracket far outweigh the possible negative ramifications of not.

Regarding social gatherings, transportation is clear, housing/hotel accommodations are clear. Typical gatherings involve a wide variety of people of different age demographics/ professions 

Can you travel -->  Yes 

Safe for children -->  Yes

Safe for young adults --> Yes

Safe for middle age adults  --> Yes 

Safe for upper middle age adults --> Yes 

Safe for older adults --> likely 

Safe for the elderly --> most likely (most cautious for respiratory viral exposure) 

Other Concerns 

Food Preparation/Smoke/Nutrition/Exertion  

Accommodations/housing/sleeping/rest conditions 

Proper Outer Coverings/Stay Warm/Avoid temperature fluctuations 

Health benefits/social gatherings/life events/etc.

Influenza Related Deaths in the United States is the Number Eight Leading Cause of Death for Americans

Ending COVID 

Major Causes of Death Reported by the Medical Examiner in the United States

The statistics below is a brief accumulation of the current causes of death (death rate) for  the American public. The data implies that the major causes of death in the United States is following a typical pattern from the previous decade 2000-2010. Currently at the end of this decade, 2010-2020 the factors have not changed. In addition the expectation of a large discrepancy or decline in either of the main factors has not transpired. 

The primarily causes of death for the American population continue to be heart disease and cancer. Both coming in as the top two causes of death for humans in the United States. 

Heart disease is the number one cause of death at 655,381. Cancer is the number two cause of death at 599,274. The area of focus currently is respiratory infections such as influenza. Deaths associated to respiratory infections related to influenza/H1N1/pneumonia are listed as the 8th leading contributor. Chronic lower respiratory disease is listed as the 4th leading cause of death at 159,486. This is clearly where the discrepancy appears.  

Official statistics listed: Data for the United States

Mortality rate: 867.8 deaths per 100,000 (population percentage)

Number of deaths: 2,839,205

Life expectancy: 78.7 years

Infant Mortality rate: 5.66 deaths per 1,000 live births (1st world Index)

1. Heart disease: 655,381

2. Cancer: 599,274

3. Accidents (unintentional injuries): 167,127

4. Chronic Lower Respiratory Diseases: 159,486

5. Stroke (cerebrovascular diseases/nervous): 147,810

6. Alzheimer’s Disease (nervous condition): 122,019

7. Diabetes (condition) : 84,946

8. Influenza and Pneumonia (respiratory) : 59,120

9. Nephritis, Nephrotic syndrome, and Nephrosis: 51,386

10. Suicide: 48,344

It is unclear where the current statistics regarding respiratory disease related deaths being attributed to COVID are originating from. The analysis of the statistics regarding respiratory disease related deaths being attributed to COVID is vague.

Previous health conditions (heart disease, stroke, cancer),  underlying medical ailments (diabetes, previous respiratory infections, surgical procedures, etc.), as well as lifestyle decisions (smoking, obesity) can all contribute to an individuals demise. 

The Artificial Development & Inducement of Antibody Production through the Immune System

Ending COVID 

Adaptive Immunity 

How the Body Creates Antibodies (Artificial Inducement) 

Note: This is a briefing on how antibodies are formed, however it is important to remember that most people do not currently need the COVID Vaccine at this point, in order to resume living, as most have already been exposed to the virus, and have created antibodies via a natural process through their immune system. 

Starting with a return to discussing what antibodies (or immunoglobulins (Ig)) are and how they form in the human body. Antibodies are important because the immune system needs them to fight of foreign invaders into the body, such as a virus like COVID. 

The antibody is a small protein molecule that is designed to identify and bind to a specific part of the virus as soon as it enters the body. The surface where the antibody binds to is called an antigen, the location on the surface is referred to as an antigenic site or epitope. There are a variety of different types of antibodies, IgG, IgA, IgM, IgD, and Ig E. Usually the amount of antibodies found in the human body is quite low, however when a virus (antigen/pathogen) enters the body the immune system responds, by increasing the amount produced. 

The first time the human immune system sees a new antigen (a foreign unrecognizable pathogen) it needs to prepare to destroy it. Once an antigen/pathogen (such as a virus) enters the body, it can multiply and cause symptoms leading to illness. However, if the immune system creates antibodies targeted towards the identified antigen, then when the same antigen is seen again, the immune system is poised to confine and destroy the antigen/pathogen. This is the process known as adaptive immunity in the immune system. 

Creating adaptive immunity towards viruses found in the environment, is important to maintaining good health in the human body. The primary way that the immune system creates antibodies is through the natural process known as adaptive immunity, however there are ways to induce this process artificially, one such way is by using a vaccine. 

In this case, when the live pathogen (virus such as COVID) infects the body, the response is rapid and the pathogen is prevented from causing the targeted illness. In order to trigger this adaptive immunity process and immune memory a vaccine will expose the body to the targeted antigen/pathogen (such as the COVID virus), without causing the disease.  And reducing the presence of symptoms in an ideal situation, preventing further damage to the human body. This is the case for those who have not already been exposed to the virus.  

Although vaccines are crucial when a person is young, to help the immune system, those past that stage are usually capable of fighting of invading viruses, using their own immune system to some extent (however highly advisable to get one if not previously exposed, especially if traveling). After natural exposure to a viral strain, the body has already developed antibodies to fight of the incoming virus. Once a vaccine is widely available, those who are immuno-compromised (weak immune system), or the elderly are the ones who are going to need it most.

The rest of the population can choose whether to get vaccinated or not, depending on the strain present, and prior exposure. Similar to the yearly flu shot (influenza/H1N1, etc.), vaccines can change annually, in order to be relevant to the virus targeted. At this time it is not of extreme concern, to seize normal living in a population which has already been heavily exposed to a virus.    

The Importance of Opening All Schools

Ending COVID 

Why Schools Across the Country should be Opened 

If you have ever broken a body part such as an arm or a leg, you will be familiar with the concept of wearing a cast. Restricting movement of a broken bone, which requires a splint, sling, brace or cast, is critical to healing, to prevent any further injury from occurring. However when you remove the cast, the first thing you will notice is how different your body part has become. Healed and placed back in the correct position it may be, but how does it actually feel. Most likely it will be very weak, flaccid, and awkward for you to move around and utilize.

This is what happens when we freeze our body parts in time, by no longer using them. It only takes 2 weeks of non-usage of our body parts for bone atrophy to start. A similar situation can also occur to our mind. The concept of "use it or lose it," is never more apparent than in the case of our nervous system. The more you learn (how to do something) the easier it becomes to do everything, usually.   

This is particularly the case during the developmental stages of most humans. Starting from the age of 2 our mind works in overdrive to process the environmental information surrounding us and try to make sense of it. The more time spent in understanding our environment (from the ages of 2-18), the better we become at forming neural networks. After this stage the nervous system continues to develop throughout a lifetime, and we can continue to create new patterns as we age. However taking out the time to read and learn, along with socialize with individuals in our own peer group is crucial to our development as a species. 

Educational systems allow individuals to spend an allocated time everyday enriching ourselves in learning activities which develop the nervous system. Doing so results in a lifetime of healthy functioning and enforcing societal values which are learning based. Our society is based on healthy positive social interactions with other individuals, and this is first enforced during our early educational days.   

The immune systems of children are in different developmental stages than of adults. Having already been exposed to a wide variety of colds and fighting them of, they are highly unlikely to be impacted by novel viruses such as COVID. In addition, since they are at the first stage of living, and they have recently been vaccinated, they have healthy immune systems (in most cases).

While it is true that children of all ages can become infected with COVID, most who are infected, will not become as sick as an adult. In addition the vast majority will be asymptomatic. There are quite a few schools that have been open in the United States for sometime now, and they have not had any adverse effects regarding COVID openings. 

Children with preexisting health conditions such as asthma, diabetes, congenital heart disease, nervous system conditions, obesity, respiratory conditions, etc. might be at a higher risk of contracting respiratory infections such as COVID. However while most children of all ages can get infected with COVID (and other viruses), most do not become as ill as adults, and are usually mild or asymptomatic. 

Therefore while it is possible for children to contract COVID, it is unlikely that it will result in a life threatening circumstance, as most have mild symptoms or none at all. Hence it does not appear to be feasible to take the chance of closing the educational system preventing access to education. 

The Natural Development of Antibodies as a Defense Strategy Utilized by the Human Immune System Against Viral Infections

Beyond COVID

The Natural Development of Antibodies by the Human Immune System 

Presence of COVID Antibodies

How exposure to a virus results in the development of antibodies as a defense response mechanism by the human immune system. 

Antibodies develop naturally in the human body through exposure of foreign entities such as viruses (SARS-COV2). The presence of antibodies help protect the human body from fighting of viral infections (such as COVID) by identifying them when they first enter the body, and block them from attaching to healthy cells. 

An antibody is a protective entity that is created by the human immune system due to the presence of a foreign substance referred to as an antigen. The antibody recognizes and attaches itself to the antigen and then proceeds to attempt to remove it from the body. 

When a foreign substance is able to enter the body, the first thing that occurs is that the immune system recognizes it as a foreign entity. The surface layer of antigens have molecules that are different from those found in the body, which allow the immune system to verify its uniqueness.  

To eliminate the invader, the immune system calls on a number of mechanisms, including one of the most important—antibody production. Antibodies are produced by specialized white blood cells called B lymphocytes (or B cells). When an antigen binds to the B-cell surface, it stimulates the B cell to divide and mature into a group of identical cells called a clone. The mature B cells, called plasma cells, secrete millions of antibodies into the bloodstream and the lymphatic system. 

Once the immune system has initiated a response to the invasion, the production of antibodies goes into overdrive producing millions at a time. The cardiovascular system circulates them via the bloodstream throughout the body. As the antibodies circulate utilizing the bloodstream, they attack and neutralize antigens that are identical to the one (alien) that triggered the immune response. The antibody first binds to the antigen in order to initiate the attack. Binding to the toxin (such as a virus (COVID)) can neutralize the poison simply by changing its chemical composition, these antibodies are called antitoxins. 

Once the antibodies attach themselves to the invading virus, multiple features of the immune system can be initiated to further eliminate the virus from attacking the body. The invading microorganisms can become inactive and will no longer be able to attach and invade the human healthy cells. 

At this point the initial attack of the immune system has resulted in a a series of responses primarily that regarding antibody production. The ongoing production of antibodies continues for several days until all the antigen molecules of the targeted virus (COVID) are removed. Antibodies remain in circulation for several months, providing extended immunity against that particular antigen.

Therefore, the presence of these antibodies within the human body such as those provided by the exposure of COVID, will attack the virus, and will help the body recover. In addition the ongoing presence of COVID antibodies within the body will protect the body from being infected again from the virus, similar to a vaccine.  

Beyond COVID

SARS-COV2 

Why we Should Move on from COVID Concerns

1. Virus is from 2019 at latest which means it has been circulating in the environment for a while.

2. The vast majority of the population has already been exposed to the virus since the previous year 2019. As is evident in states such as California and Texas 1 million plus cases.

3. First virus cycle ended earlier this year, we are now in the second cycle, already November 2020.

4. Since most of us have already been exposed to the virus, our body has developed antibodies (things that fight of and kill the virus in our body).

5. Antibodies formed from our immune system, identify, and fight of the virus when our body first comes across it, and protect us naturally (unless the individual is very weak).

6. Having already been exposed to the virus and already developed antibodies for protection, we do not need a vaccine shot in order to resume normal lives.

7. When the vaccine becomes available it will put a small amount of the virus in your body to help your body develop antibodies. That is all that happens with vaccination. People can utilize it for additional protective measures, advisable.

8. Most deaths attributed have come from other medical causes and are directly related to the natural aging process.

9. Current measures involving social distancing and banning gatherings can be counterproductive to the healthy aging process.

10. Wearing masks will not work for a virus that you have been most likely already exposed to.

11. There is nothing wrong with practicing healthy hygiene practices to protect you from general flu related respiratory illness however they are not the major causes of death for most people. Stressful enforcement mandates are counterproductive to good health. 

12. Several pandemics have occurred in the recent past and have not had such widescale ramifications (SARS 2003, H1N1 2009, etc.).

Beyond COVID Previous Influenza Outbreaks throughout History

The Historical Precedence of Influenza Identification, Spread and Eventual Adaptation into the Population   

What is Influenza 

Influenza, also referred to as the flu, is a respiratory infectious disease that is caused by a negative-sense RNA virus (Orthomyxoviridae). The most common types of influenza viruses that impact the human population include Type A, Type B, and Type C. The virus strain spreads around the world in yearly outbreaks. An influenza pandemic occurs when a strain of the virus is transmitted to the human body (usually from another species) and spreads massively. This may also result in the identification of a new strain of the virus. 

Examples of Influenza Pandemics (not comprehensive)

1918-1919 

H1N1 Influenza A virus 

1930's

Influenza B virus 

1940's 

Inactivated Flu vaccine 

For inactivated Influenza A virus 

1940's

Influenza B viruses discovered 

Arrival of Mechanical ventilators 

1942

Two dose Flu vaccine 

Protection against Influenza A & Influenza B virus

1947

Flu epidemic 

Changes in antigenic composition of influenza viruses 

Rendered existing vaccines ineffective

Required to renew annually  

Monitor international circulating viral strains 

1957

Flu pandemic

H2N2 novel flu virus emerges 

1960

1st Recommendation for annual Influenza vaccination 

Over 65/very weak/immunocompromised

1960's

South Africa outbreak 

Reservoir for influenza A virus (wild birds)

H3N2 new influenza virus emerges 

pandemic 

1970's 

H1N1 swine flu 

25% of US pop vaccinated 

twice the level needed to block pandemic 

1996

H5N1 virus avian influenza 

Hong Kong

2003 

SARS I epidemic 

China 

2007

H5N1

US Vaccine 

2009 

H1N1 pandemic

new influenza A virus 

Mexico

2020 

SARS-COV-2

COVID pandemic 

China 

There are many viral strains currently circulating worldwide and this does not interfere with daily living

Management of previous epidemics 

Resulting consequences

Current management of COVID/SARS-COV-2 

Beyond COVID Acquiring Test Percentages & Data Analysis

Viral infection testing and biomarker indicators are developed and utilized throughout the vast majority of the population in the case of identifying the presence of a virus during the preliminary stages of prevention. Tests are developed by utilizing viral antigens on the surface of cells infected with a specific virus. The viral antigen detection test is done with a sample of tissue that could be infected. Antibodies that are tagged (have a dye or tracer to identify as a biomarker) attach to those viral antigens when mixed with the sample to determine if a specimen is positive or not.  

The most common test used for viral diagnosis are antigen detection. Methods of antigen detection include fluorescent antibody staining, immuno-peroxidase staining, etc. which are used for identifying positive and negative biomarkers to determine the appearance of a viral infection. 

Once a new strain of a virus has been confirmed, it is feasible to immediately develop a complementary viral infection test to prevent the spread of the virus. After these specific tests have been developed, they can be used at the preliminary stages of identification, in order to determine the presence of a new strain of a virus within a given population, to prevent an epidemic. 

Using a small subgroup of the population, the tests can be immediately used to determine the percentage infected within a population, to prevent further spread. These tests will also show the percentage of individuals who are asymptomatic, as well as have mild to moderate symptoms upon infection. While testing for virus infections is feasible during the preliminary stages to prevent an epidemic, once the percentage infected surpasses a certain point, it becomes futile. The data accumulated can be used for epidemiological studies but these can again be obtained using a much smaller sample (a hundred). It is far more feasible to test smaller subgroups of the population to obtain statistics and data rather than large ones. The critical point is to identify whether a threshold as been reached, in which the population can resume regular activities without restrictions.  

Data Analysis 

Additional Percentage Margins to consider regarding testing results can include: %

Percentage Infected %

Percentage Positive % 

Percentage Asymptomatic % 

Percentage Negative %

New Margin/Mean/Average/Median

Margin for Infected vs. Uninfected Population

Margin for Adaptability into Immune System 

Margin for Antibody Presence 

Percent Immunity %

Daily/Weekly/Monthly assessment

Cost Assessment Percentage (person/city/state/country) 

Cost of Development 

Cost of Implementation 

Annual Viral Cycle 

Beyond COVID - California and Texas Hit 1 Million Positive COVID Cases Milestone

The states of California and Texas have both reached over 1 million cases of positive COVID individuals. This means that over one million people have already been tested for COVID and tested positive. Asymptomatic or not, the positive results imply that, in a region with over 39 million individuals (California) and 29 million individuals (Texas) most people are testing positive. As a result of this, the chances that the vast majority of the population has already been exposed to the virus is very likely.

These testing results can be utilized as a measure of how many people have already been infected in the case of a small group of individuals, when trying to prevent a spread from occurring. However, once a certain margin has passed, it becomes futile to prevent the spread, as it has already transpired throughout the population, especially in densely populated areas such as California and Texas. 

As the vast majority of the population becomes exposed in the United States, the chances of the human body developing immunity and being able to fight of the virus without the presence of a vaccine, or recovery treatment, increases. At this point it appears that the vast majority of the population has developed that capability to fight of the viral infection on its own, without a significant cost to the immune system for this viral cycle.

Beyond COVID Media Reporting that US is Easing Restrictions

News outlets arereporting that there are plans to reduce American government mandates, which is good. All states should re-open at full capacity including businesses, schools, organizations and limit restrictions. This should proceed as quickly as possible. Especially before the cold weather sits in, so people do not get further confused with symptoms from the cold, flu, bronchitis, etc. The situation has gone to far at this point for any health measures to be even remotely feasible, other than to accumulate data for epidemiological study purposes (testing results).

Almost everyone has already been exposed and for the few that might have actual ramifications, there is an approved treatment and vaccine on the market. Which would be utilized only in the worst case scenario. Deaths attributed could be from a wide combination of factors that contribute to cause of death, including previous cardiac failures, cancers, organ dysfunction, other ailments, and general aging which lead to mortality from a virus (not correctly classified). Highly advisable to resume normal life at full scale from this point except for the immune compromised, which would have been the case regardless.